Greater occipital and supraorbital nerve blockade for the preventive treatment of migraine: a single-blind, randomized, placebo-controlled study

References

• Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders (beta version). Cephalalgia 2013;33:629-808
   PubMed Web of Science ®Google Scholar
• Merikangas KR. Contributions of epidemiology to our understanding of migraine. Headache 2013;53:230-46
   PubMed Web of Science ®Google Scholar
• Steiner TJ, Stovner LJ, Birbeck GL. Migraine: the seventh disabler. Headache 2013;53:227-9
   PubMed Web of Science ®Google Scholar
• Lipton RB, Stewart WF, Diamond S, et al. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001;41:646-57
   PubMed Web of Science ®Google Scholar
• Pringsheim T, Davenport WJ, Marmura MJ, et al. How to apply the AHS evidence assessment of the acute treatment of migraine in adults to your patient with migraine. Headache 2016;56:1194-200
   PubMed Web of Science ®Google Scholar
• Blumenfeld AM, Bloudek LM, Becker WJ, et al. Patterns of use and reasons for discontinuation of prophylactic medications for episodic migraine and chronic migraine: results from the second international burden of migraine study (IBMS‐II). Headache 2013;53:644-55
   PubMed Web of Science ®Google Scholar
• Terzi T, Karakurum B, Ucler S, et al. Greater occipital nerve blockade in migraine, tension-type headache and cervicogenic headache. J Headache Pain 2002;3:137-41
   Google Scholar
• Tobin JA, Flitman SS. Occipital nerve blocks: effect of symptomatic medication. Headache 2009;49:1479-85
   PubMed Web of Science ®Google Scholar
• Naja ZM, El-Rajab M, Al-Tannir MA, et al. Occipital nerve blockade for cervicogenic headache: a double‐blind randomized controlled clinical trial. Pain Pract 2006;6:89-95
   PubMedGoogle Scholar
• Peres MFP, Stiles MA, Siow HC, et al. Greater occipital nerve blockade for cluster headache. Cephalalgia 2002;22:520-2
   PubMed Web of Science ®Google Scholar
• Tang Y, Kang J, Zhang Y, et al. Influence of greater occipital nerve block on pain severity in migraine patients: a systematic review and meta-analysis. Am J Emerg Med 2017;11:1750-4
   Web of Science ®Google Scholar
• Kelman L. Pain characteristics of the acute migraine attack. Headache 2006;46:942-53
   PubMed Web of Science ®Google Scholar
• Chakravarty A, Mukherjee A, Roy D. Migraine pain location in adult patients from eastern India. Ann Indian Acad Neurol 2008;11:98-102
   PubMed Web of Science ®Google Scholar
• Caputi CA, Firetto V. Therapeutic blockade of greater occipital and supraorbital nerves in migraine patients. Headache 1997;37:174-9
   PubMed Web of Science ®Google Scholar
• Piñero MR, Carrillo PM, Hueso P, et al. Pericranial nerve blockade as a preventive treatment for migraine: experience in 60 patients. Neurología 2016;31:445-51
   PubMed Web of Science ®Google Scholar
• Schoenen J, Vandersmissen B, Jeangette S, et al. Migraine prevention with a supraorbital transcutaneous stimulator, a randomized controlled trial. Neurology 2013;80:697-704
   PubMed Web of Science ®Google Scholar
• Reed KL, Black SB, Banta CJ, et al. Combined occipital and supraorbital neurostimulation for the treatment of chronic migraine headaches: initial experience. Cephalalgia 2010;30:260-71
   PubMed Web of Science ®Google Scholar
• Hann S, Sharan A. Dual occipital and supraorbital nerve stimulation for chronic migraine: a single-center experience, review of literature, and surgical considerations. Neurosurg Focus 2013;35:E9
   PubMed Web of Science ®Google Scholar
• Macedo A, Baños JE, Farré M. Placebo response in the prophylaxis of migraine: a meta‐analysis. Eur J Pain 2008;12:68-75
   PubMed Web of Science ®Google Scholar
• Diener HC, Hartung E, Chrubasik JA, et al. A comparative study of oral acetylsalicyclic acid and metoprolol for the prophylactic treatment of migraine. A randomized, controlled, double-blind, parallel group phase III study. Cephalalgia 2001;21:120-8
   PubMed Web of Science ®Google Scholar
• Klapper JO, Divalproex Sodium in Migraine Prophylaxis Study Group. Divalproex sodium in migraine prophylaxis: a dose-controlled study. Cephalalgia 1997;17:103-8
   PubMed Web of Science ®Google Scholar
• Brandes JL, Saper JR, Diamond M, et al. Topiramate for migraine prevention: a randomized controlled trial. JAMA 2004;291:965-73
   PubMed Web of Science ®Google Scholar
• Srbely JZ, Dickey JP, Lee D, et al. Dry needle stimulation of myofascial trigger points evokes segmental anti-nociceptive effects. J Rehabil Med 2010;42:463-8
   PubMed Web of Science ®Google Scholar
• Linde K, Allais G, Brinkhaus B, et al. Acupuncture for tension-type headache. Cochrane Database Syst Rev 2016;4:CD007587
   Google Scholar
• Hesse J, Møgelvang B, Simonsen H. Acupuncture versus metoprolol in migraine prophylaxis: a randomized trial of trigger point inactivation. J Intern Med 1994;235:451-6
   PubMed Web of Science ®Google Scholar
• Ashkenazi A, Matro R, Shaw JW, et al. Greater occipital nerve block using local anaesthetics alone or with triamcinolone for transformed migraine: a randomised comparative study. J Neurol Neurosurg Psychiatry 2008;79:415-17
   PubMed Web of Science ®Google Scholar
• Inan LE, Inan N, Karadas O, et al. Greater occipital nerve blockade for the treatment of chronic migraine: a randomized, multicenter, double-blind, and placebo-controlled study. Acta Neurol Scand 2015;132:270-7
   PubMed Web of Science ®Google Scholar
• Kashipazha D, Nakhostin-Mortazavi A, Mohammadianinejad SE, et al. Preventive effect of greater occipital nerve block on severity and frequency of migraine headache. Glob J Health Sci 2014;6:209-13
   PubMedGoogle Scholar
• Palamar D, Uluduz D, Saip S, et al. Ultrasound-guided greater occipital nerve block: an efficient technique in chronic refractory migraine without aura? Pain Physician 2015;18:153-62
   Google Scholar
• Cuadrado ML, Aledo-Serrano A, Navarro P, et al. Short-term effects of greater occipital nerve blocks in chronic migraine: a double-blind, randomised, placebo-controlled clinical trial. Cephalalgia 2017;37:864-72
   PubMed Web of Science ®Google Scholar
• Dilli E, Halker R, Vargas B, et al. Occipital nerve block for the short-term preventive treatment of migraine: a randomized, double-blinded, placebo-controlled study. Cephalalgia 2015;35:959-68
   PubMed Web of Science ®Google Scholar
• Dimitriou V, Iatrou C, Malefaki A , et al. Blockade of branches of the ophthalmic nerve in the management of acute attack of migraine. Middle East J Anaesthesiol 2002;16:499-504
   PubMedGoogle Scholar
• Ambrosini A, Vandenheede M, Rossi P, et al. Suboccipital injection with a mixture of rapid-and long-acting steroids in cluster headache: a double-blind placebo-controlled study. Pain 2005;118:92-6
   PubMed Web of Science ®Google Scholar
• Anthony M. Headache and the greater occipital nerve. Clin Neurol Neurosurg 1992;94:297-301
   PubMed Web of Science ®Google Scholar
• Ashkenazi A, Young WB. The effects of greater occipital nerve block and trigger point injection on brush allodynia and pain in migraine. Headache 2005;45:350-4
   PubMed Web of Science ®Google Scholar
• Young W, Cook B, Malik S, et al. The first 5 minutes after greater occipital nerve block. Headache 2008;48:1126-8
   PubMed Web of Science ®Google Scholar
• Goadsby PJ, Lipton RB, Ferrari MD. Migraine–current understanding and treatment. N Engl J Med 2002;346:257-70
   PubMed Web of Science ®Google Scholar
• Bernstein C, Burstein R. Sensitization of the trigeminovascular pathway: perspective and implications to migraine pathophysiology. J Clin Neurol 2012;8:89-99
   PubMed Web of Science ®Google Scholar
• Bartsch T, Goadsby PJ. The trigeminocervical complex and migraine: current concepts and synthesis. Curr Pain Headache Rep 2003;7:371-6
   PubMedGoogle Scholar
• Knize DM. A study of the supraorbital nerve. Plast Reconstr Surg 1995;96:564-9
   PubMed Web of Science ®Google Scholar